Macrophages have been shown to play crucial roles in prostate cancer progression, including their involvement in signaling pathways, therapy resistance, and modulation of immune checkpoint blockade therapies such as PD-1/PD-L1 targeted strategies [22,27,28,29]. The gene discussed is PDCD1; the disease is Familial prostate cancer.